122 related articles for article (PubMed ID: 15154615)
1. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model.
Ziporen L; Polak-Charcon S; Korczyn DA; Goldberg I; Afek A; Kopolovic J; Chapman J; Shoenfeld Y
Clin Dev Immunol; 2004 Mar; 11(1):67-75. PubMed ID: 15154615
[TBL] [Abstract][Full Text] [Related]
2. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.
Ziporen L; Shoenfeld Y; Levy Y; Korczyn AD
J Clin Invest; 1997 Aug; 100(3):613-9. PubMed ID: 9239409
[TBL] [Abstract][Full Text] [Related]
3. Lessons from experimental APS models.
Shoenfeld Y; Ziporen L
Lupus; 1998; 7 Suppl 2():S158-61. PubMed ID: 9814695
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
5. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
6. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome.
Yodfat O; Blank M; Krause I; Shoenfeld Y
Clin Immunol Immunopathol; 1996 Jan; 78(1):14-20. PubMed ID: 8599879
[TBL] [Abstract][Full Text] [Related]
7. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
8. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome.
Tanne D; Katzav A; Beilin O; Grigoriadis NC; Blank M; Pick CG; Landenberg Pv; Shoenfeld Y; Chapman J
Neurobiol Dis; 2008 Apr; 30(1):56-64. PubMed ID: 18308578
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.
Weiss R; Bitton A; Nahary L; Arango MT; Benhar I; Blank M; Shoenfeld Y; Chapman J
Immunol Res; 2017 Feb; 65(1):355-362. PubMed ID: 27449504
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
[TBL] [Abstract][Full Text] [Related]
11. Identification of anti-moesin antibodies in the serums of patients with antiphospholipid syndrome.
Lin X; Liang Q; Lin L; Ding Q; Wang X; Wang Y
Thromb Res; 2015 May; 135(5):867-72. PubMed ID: 25743886
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
14. IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome.
Katzav A; Menachem A; Maggio N; Pollak L; Pick CG; Chapman J
J Autoimmun; 2014 Dec; 55():86-93. PubMed ID: 25150791
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome and the idiotypic network.
Bakimer R; Blank M; Kosashvilli D; Ichikawa K; Khamashta MA; Hughes GR; Koike T; Shoenfeld Y
Lupus; 1995 Jun; 4(3):204-8. PubMed ID: 7655490
[TBL] [Abstract][Full Text] [Related]
16. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome.
Katzav A; Litvinjuk Y; Pick CG; Blank M; Shoenfeld Y; Sirota P; Chapman J
Behav Brain Res; 2006 May; 169(2):289-93. PubMed ID: 16530276
[TBL] [Abstract][Full Text] [Related]
17. Factor XIII in primary antiphospholipid syndrome.
Ames PR; Iannaccone L; Alves JD; Margarita A; Lopez LR; Brancaccio V
J Rheumatol; 2005 Jun; 32(6):1058-62. PubMed ID: 15940768
[TBL] [Abstract][Full Text] [Related]
18. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
[TBL] [Abstract][Full Text] [Related]
19. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of the antiphospholipid syndrome.
Chaturvedi S; McCrae KR
Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
